Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunobiology. 2014 Dec;219(12):975-9. doi: 10.1016/j.imbio.2014.07.005. Epub 2014 Jul 21.

Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD).

Author information

1
Lung Institute of Western Australia, The University of Western Australia, Perth, Australia; Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Australia; School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia. Electronic address: dino.tan@uwa.edu.au.
2
School of Pathology and Laboratory Medicine, The University of Western Australia, Perth, Australia.
3
School of Pathology and Laboratory Medicine, The University of Western Australia, Perth, Australia; Department of Clinical Immunology, Royal Perth Hospital, Perth, Australia.
4
Lung Institute of Western Australia, The University of Western Australia, Perth, Australia; Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Australia; School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia.
5
Lung Institute of Western Australia, The University of Western Australia, Perth, Australia; Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Australia; School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia; Department of Respiratory and Sleep Medicine, Royal Perth Hospital, Perth, Australia.

Abstract

Anti-inflammatory pathways affecting chronic obstructive pulmonary disease (COPD) are poorly understood. Regulatory T-cells (Tregs) are important negative regulators of T-cell activity and hence were investigated in COPD patients in this study. We hypothesised that functional defects in Tregs may promote increased inflammation contributing to the pathogenesis of COPD. Peripheral blood mononuclear cells (PBMC) were isolated from patients with stable COPD and age-matched non-smoking controls. Treg-mediated suppression of memory non-Treg (Foxp3(-)CD45RO(+)) CD4(+) T-cell activation was analysed by comparing PBMC responses to staphylococcal enterotoxin-B (SEB) pre- and post-depletion of Tregs (CD25(+)CD127(low)CD4(+) T-cells) by fluorescence-activated cell sorting (FACS). Activation of T-cells was assessed by HLA-DR expression. Levels of secreted cytokines were measured by ELISA. Depletion of Tregs increased SEB-induced activation of Foxp3(-)CD45RO(+) CD4(+) T-cells in samples from 15/15 healthy controls (demonstrating Treg-mediated suppression) and 9/14 COPD patients (Fisher's test, p=0.017). A screen of clinical data associated a failure of Treg-mediated suppression in the remaining five COPD patients with a higher body mass index (BMI) (33-38 kg/m(2)) compared to patients with unimpaired Treg function (20-32 kg/m(2)). In conclusion, we demonstrate impaired Treg-mediated suppression of CD4(+) T-cell activation in a subset of COPD patients, all of whom had high BMI. Obesity and/or perturbed homeostasis of Treg subsets may explain this defect and therefore contribute to increased inflammation observed in COPD.

KEYWORDS:

Anti-inflammatory; COPD; Foxp3; Obesity; Regulatory T-cells

PMID:
25097153
DOI:
10.1016/j.imbio.2014.07.005
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center